David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.1% |
| 2 | Technology | 16.45% |
| 3 | Consumer Discretionary | 10.49% |
| 4 | Communication Services | 9.04% |
| 5 | Healthcare | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MNDT
2126
PUT
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $2.93M | ﹤0.01% |
149,500
+129,500
| +648% | +$2.71M |
|
2127
Paychex
PAYX
$45.2B
| $2.92M | ﹤0.01% |
29,834
-315,625
| -91% | -$29.1M |
|
2128
Peapack-Gladstone Financial
PGC
$800M
| $2.92M | ﹤0.01% |
94,665
-14,815
| -14% | -$407K |
|
|
GES
2129
CALL
DELISTED
Guess Inc
GES
| $2.92M | ﹤0.01% |
+124,300
| New | +$3.06M |
|
2130
CALL
XPeng
XPEV
$10.9B
| $2.92M | ﹤0.01% |
+80,000
| New | +$3.33M |
|
2131
Mid-America Apartment Communities
MAA
$15B
| $2.92M | ﹤0.01% |
20,200
+8,187
| +68% | +$1.11M |
|
|
ATIP
2132
DELISTED
ATI Physical Therapy, Inc.
ATIP
| $2.91M | ﹤0.01% |
5,846
-5,239
| -47% | -$2.87M |
|
2133
Mistras Group
MG
$608M
| $2.91M | ﹤0.01% |
255,320
-17,814
| -7% | -$158K |
|
2134
CALL
Magnite
MGNI
$3.37B
| $2.91M | ﹤0.01% |
+70,000
| New | +$3.03M |
|
2135
EverQuote
EVER
$885M
| $2.91M | ﹤0.01% |
80,161
-47,472
| -37% | -$2.02M |
|
2136
CALL
SLB Ltd
SLB
$80.5B
| $2.91M | ﹤0.01% |
107,000
-146,100
| -58% | -$3.85M |
|
|
RMGCU
2137
DELISTED
RMG Acquisition Corp. III Unit
RMGCU
| $2.91M | ﹤0.01% |
+292,146
| New | +$3.04M |
|
|
HIMX
2138
Himax Technologies
HIMX
$2.46B
| $2.91M | ﹤0.01% |
212,889
-153,413
| -42% | -$1.79M |
|
|
LCAAU
2139
DELISTED
L Catterton Asia Acquisition Corp Units
LCAAU
| $2.9M | ﹤0.01% |
+291,885
| New | +$2.92M |
|
|
WOW
2140
DELISTED
WideOpenWest
WOW
| $2.9M | ﹤0.01% |
213,551
-2,566
| -1% | -$33.7K |
|
2141
Diageo
DEO
$51.4B
| $2.9M | ﹤0.01% |
17,656
-13,969
| -44% | -$2.29M |
|
2142
Zebra Technologies
ZBRA
$17.3B
| $2.88M | ﹤0.01% |
5,947
-8,290
| -58% | -$3.7M |
|
2143
Steris
STE
$22.8B
| $2.88M | ﹤0.01% |
15,112
-72,739
| -83% | -$13.5M |
|
2144
PUT
Eastman Chemical
EMN
$8.32B
| $2.87M | ﹤0.01% |
26,100
| – | – |
|
2145
Brink's
BCO
$4.54B
| $2.87M | ﹤0.01% |
36,263
-51,375
| -59% | -$3.88M |
|
2146
CALL
Fair Isaac
FICO
$25.3B
| $2.87M | ﹤0.01% |
5,900
| – | – |
|
2147
Arlo Technologies
ARLO
$1.42B
| $2.86M | ﹤0.01% |
455,329
-302,801
| -40% | -$2.37M |
|
2148
Lam Research
LRCX
$396B
| $2.86M | ﹤0.01% |
48,010
-431,510
| -90% | -$23.5M |
|
2149
CALL
Elastic
ESTC
$8.78B
| $2.85M | ﹤0.01% |
25,600
+10,100
| +65% | +$1.43M |
|
2150
CALL
WD-40
WDFC
$2.95B
| $2.85M | ﹤0.01% |
9,300
| – | – |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $10.4B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 35% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.